(1 - 9 von 13
)
B-MS turns its back on HIV pact with Sweden's Medivir - PharmaTimes
www.pharmatimes.com
Sweden’s Medivir has been told that partner Bristol-Myers Squibb has terminated the development of the firms’ preclinical HIV compound MIV News -...
Bristol-Myers Squibb Axes Development of Anti-HIV Candidate
www.genengnews.com
While the company was eligible to milestones worth $97 million and double-digit royalties, Bo Oberg, CEO of Medivir HIV Franchise, is satisfied ...
BMS Drops Medivir HIV Drug - Contract Pharmawww.contractpharma.com › view_breaking-news
www.contractpharma.com
· ... that by far exceed Medivir's investments in the project" said professor Bo Oberg, chief executive officer of Medivir HIV Franchise AB.
Swedish biotech licenses HIV drug to China for development | aidsmap
www.aidsmap.com
Professor Bo Oberg, head of the HIV franchise at Medivir, told aidsmap: “This should enhance the safety of condoms and will at least save a few ...
sortiert nach Relevanz / Datum